Translational Research Technologies (TRT) Division

Overview

The Translational Research Technology Division (TRT) provides a one-stop shop of flexible laboratory-based services for translational studies to members of the CTRI and external collaborators. We support a broad range of clinical and translational research projects by providing Biorepository, Sample Acquisition, and Laboratory (bio-analytical, and assay development) services. We also can coordinate seamless access to services external to the CTRI, including Affiliated Laboratories that provide drug discovery, proteomics, and imaging. Services may be recharged or paid through a purchase order.

Accessing TRT Cores, Services, and Consultation

Requests for services should be routed through the “Request CTRI Services” button above. If investigators cannot locate a particular resource or service, they are encouraged to contact us (at ctrilab@ucsd.edu) so we can explore ways to meet their needs.

TRT Advisory Committee

The TRT Advisory Committee oversees all aspects of the Division's ongoing and planned activities. The Co-Chairs are Paul J. Mills and David Boyle; other members are Elizabeth Komives, and Scott Vandenberg (see below for contact information). The Committee explores new research directions, and determines potential new services that could facilitate such research.

TRT External Advisory Committee

The TRT External Advisory Committee independently evaluates and guides the directions and activities of the TRT, providing external expertise in the domains of basic, applied, clinical and translational research. Committee members include Chris Benedict PhD, Mary Corr MD, Scott Matthews, MD, Simon Schenk, PhD, and Mark Wallace, MD.

TRT Seminar Series

TRT hosts a quarterly Seminar Series showcasing various technologies and testing services that support clinical and translational research. For more information and a list of upcoming lectures, click Seminar Series.

Catalyst Grants

Funding Announcement: New Drug Discovery Catalyst Grant Program

Funding Announcement: Proteomics Catalyst Grant Program